Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness

about

Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness

Item

http://www.wikidata.org/entity/Q57480742

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Cell culture-derived influenza ...... nfluenza vaccine effectiveness

@en

Cell culture-derived influenza ...... nfluenza vaccine effectiveness

@nl

type

Item

label

Cell culture-derived influenza ...... nfluenza vaccine effectiveness

@en

Cell culture-derived influenza ...... nfluenza vaccine effectiveness

@nl

prefLabel

Cell culture-derived influenza ...... nfluenza vaccine effectiveness

@en

Cell culture-derived influenza ...... nfluenza vaccine effectiveness

@nl

P1476

Cell culture-derived influenza ...... nfluenza vaccine effectiveness

@en

P2093

Heidi Trusheim

http://www.w3.org/2001/XMLSchema#string

Ian G Barr

http://www.w3.org/2001/XMLSchema#string

John W McCauley

http://www.w3.org/2001/XMLSchema#string

Takato Odagiri

http://www.w3.org/2001/XMLSchema#string

Theodore F Tsai

http://www.w3.org/2001/XMLSchema#string

P2860

Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza

Surface modifications of influenza proteins upon virus inactivation by β-propiolactone

Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015

Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis

Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017

Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes

Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.

Egg-grown and tissue-culture-grown variants of influenza A (H3N2) virus with special attention to their use as antigens in seroepidemiology.

P2888

s41541-018-0079-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41541-018-0079-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David E. Wentworth

Jacqueline M. Katz

Ruben O Donis

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30323955

http://www.w3.org/2001/XMLSchema#string

P932

6177469

http://www.w3.org/2001/XMLSchema#string